Structural insights into the retroviral DNA integration apparatus

Current Opinion in Structural Biology

Volumn 21, Issue 2, 2011, Pages 249-256

  Cherepanov, Peter ^a   Maertens, Goedele N ^a   Hare, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; VIRUS NUCLEOPROTEIN;

AMINO ACID SEQUENCE; BASE PAIRING; CATALYSIS; CRYSTAL STRUCTURE; DNA PROTEIN COMPLEX; DNA STRAND; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SPUMA VIRUS; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; CATALYTIC DOMAIN; CHROMOSOMES, MAMMALIAN; COMPUTER SIMULATION; HIV-1; INTEGRASES; MODELS, MOLECULAR; NUCLEOPROTEINS; PROTEIN CONFORMATION; PROVIRUSES; RETROVIRIDAE; SPUMAVIRUS; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS;

EID: 79953124784     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2010.12.005     Document Type: Review

References (57)

1. Lewinski M.K., Bushman F.D. Retroviral DNA integration-mechanism and consequences. Adv Genet 2005, 55:147-181.
2. Engelman A. Reverse transcription and integration. Retroviruses: Molecular Biology, Genomics and Pathogenesis 2010, 129-159. Caister Academic Press, Norfolk, United Kingdom. R. Kurth, N. Bannert (Eds.).
3. Kulkosky J., Jones K.S., Katz R.A., Mack J.P., Skalka A.M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol 1992, 12:2331-2338.
4. Dyda F., Hickman A.B., Jenkins T.M., Engelman A., Craigie R., Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 1994, 266:1981-1986.
5. Nowotny M., Gaidamakov S.A., Crouch R.J., Yang W. Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell 2005, 121:1005-1016.
6. Davies D.R., Goryshin I.Y., Reznikoff W.S., Rayment I. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 2000, 289:77-85.
7. Richardson J.M., Colloms S.D., Finnegan D.J., Walkinshaw M.D. Molecular architecture of the Mos1 paired-end complex: the structural basis of DNA transposition in a eukaryote. Cell 2009, 138:1096-1108.
8. Hickman A.B., Chandler M., Dyda F. Integrating prokaryotes and eukaryotes: DNA transposases in light of structure. Crit Rev Biochem Mol Biol 2010, 45:50-69.
9. 2+-ion catalysis and substrate specificity. Mol Cell 2006, 22:5-13.
10. Nowotny M. Retroviral integrase superfamily: the structural perspective. EMBO Rep 2009, 10:144-151.
11. Esposito D., Craigie R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J 1998, 17:5832-5843.
12. Brin E., Leis J. HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences. J Biol Chem 2002, 277:18357-18364.
13. Bushman F., Lewinski M., Ciuffi A., Barr S., Leipzig J., Hannenhalli S., Hoffmann C. Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 2005, 3:848-858.
14. Holman A.G., Coffin J.M. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci USA 2005, 102:6103-6107.
15. Wu X., Li Y., Crise B., Burgess S.M., Munroe D.J. Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol 2005, 79:5211-5214.
16. Berry C., Hannenhalli S., Leipzig J., Bushman F.D. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2006, 2:e157.
17. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 2005, 11:1287-1289.
18. Shun M.C., Raghavendra N.K., Vandegraaff N., Daigle J.E., Hughes S., Kellam P., Cherepanov P., Engelman A. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 2007, 21:1767-1778.
19. Engelman A., Cherepanov P. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog 2008, 4:e1000046.
20. Hare S., Cherepanov P. The interaction between lentiviral integrase and LEDGF: structural and functional insights. Viruses 2009, 1:780-801.
21. Valkov E., Gupta S.S., Hare S., Helander A., Roversi P., McClure M., Cherepanov P. Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res 2009, 37:243-255.
22. Maertens G.N., Hare S., Cherepanov P. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 2010, 468:326-329.
23. McColl D.J., Chen X. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy. Antiviral Res 2010, 85:101-118.
24. Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287:646-650.
25. Espeseth A.S., Felock P., Wolfe A., Witmer M., Grobler J., Anthony N., Egbertson M., Melamed J.Y., Young S., Hamill T., et al. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc Natl Acad Sci USA 2000, 97:11244-11249.
26. Grobler J.A., Stillmock K., Hu B., Witmer M., Felock P., Espeseth A.S., Wolfe A., Egbertson M., Bourgeois M., Melamed J., et al. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc Natl Acad Sci USA 2002, 99:6661-6666.
27. Summa V., Petrocchi A., Bonelli F., Crescenzi B., Donghi M., Ferrara M., Fiore F., Gardelli C., Gonzalez Paz O., Hazuda D.J., et al. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem 2008, 51:5843-5855.
28. Engelman A., Bushman F.D., Craigie R. Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J 1993, 12:3269-3275.
29. Jaskolski M., Alexandratos J.N., Bujacz G., Wlodawer A. Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J 2009, 276:2926-2946.
30. Hare S., Gupta S.S., Valkov E., Engelman A., Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010, 464:232-236.
31. Hare S., Vos A.M., Clayton R.F., Thuring J.W., Cummings M.D., Cherepanov P. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc Natl Acad Sci USA 2010, 107(46):20057-20062.
32. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997, 71:5382-5390.
33. Farnet C.M., Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 1991, 65:1910-1915.
34. Pandey K.K., Bera S., Zahm J., Vora A., Stillmock K., Hazuda D., Grandgenett D.P. Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate. J Virol 2007, 81:12189-12199.
35. Li M., Mizuuchi M., Burke T.R., Craigie R. Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J 2006, 25:1295-1304.
36. Li M., Craigie R. Nucleoprotein complex intermediates in HIV-1 integration. Methods 2009, 47:237-242.
37. Kotova S., Li M., Dimitriadis E.K., Craigie R. Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy. J Mol Biol 2010, 399:491-500.
38. Wang J.Y., Ling H., Yang W., Craigie R. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 2001, 20:7333-7343.
39. Hare S., Di Nunzio F., Labeja A., Wang J., Engelman A., Cherepanov P. Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog 2009, 5:e1000515.
40. Baker T.A., Mizuuchi K. DNA-promoted assembly of the active tetramer of the Mu transposase. Genes Dev 1992, 6:2221-2232.
41. Delelis O., Carayon K., Guiot E., Leh H., Tauc P., Brochon J.C., Mouscadet J.F., Deprez E. Insight into the integrase-DNA recognition mechanism. A specific DNA-binding mode revealed by an enzymatically labeled integrase. J Biol Chem 2008, 283:27838-27849.
42. Deprez E., Tauc P., Leh H., Mouscadet J.F., Auclair C., Brochon J.C. Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy. Biochemistry 2000, 39:9275-9284.
43. McKee C.J., Kessl J.J., Shkriabai N., Dar M.J., Engelman A., Kvaratskhelia M. Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J Biol Chem 2008, 283:31802-31812.
44. Rabaaoui S., Zouhiri F., Lancon A., Leh H., d'Angelo J., Wattel E. Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication. Antimicrob Agents Chemother 2008, 52:3532-3541.
45. Smith R.A., Gottlieb G.S., Miller A.D. Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 2010, 7:70.
46. Krishnan L., Li X., Naraharisetty H.L., Hare S., Cherepanov P., Engelman A. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci USA 2010, 107:15910-15915.
47. Metifiot M., Marchand C., Maddali K., Pommier Y. Resistance to integrase inhibitors. Viruses 2010, 2:1347-1366.
48. Muller H.P., Varmus H.E. DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J 1994, 13:4704-4714.
49. Pryciak P.M., Sil A., Varmus H.E. Retroviral integration into minichromosomes in vitro. EMBO J 1992, 11:291-303.
50. Pruss D., Bushman F.D., Wolffe A.P. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci USA 1994, 91:5913-5917.
51. Taganov K.D., Cuesta I., Daniel R., Cirillo L.A., Katz R.A., Zaret K.S., Skalka A.M. Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro. J Virol 2004, 78:5848-5855.
52. Wang G.P., Ciuffi A., Leipzig J., Berry C.C., Bushman F.D. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 2007, 17:1186-1194.
53. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389:251-260.
54. Harper A.L., Sudol M., Katzman M. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J Virol 2003, 77:3838-3845.
55. Konsavage W.M., Burkholder S., Sudol M., Harper A.L., Katzman M. A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities. J Virol 2005, 79:4691-4699.
56. Lim K.I., Klimczak R., Yu J.H., Schaffer D.V. Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties. Proc Natl Acad Sci USA 2010, 107:12475-12480.
57. Pribil P.A., Haniford D.B. Target DNA bending is an important specificity determinant in target site selection in Tn10 transposition. J Mol Biol 2003, 330:247-259.